Leaders say FDA must focus more on public health

05/26/2009 | Wall Street Journal, The

The FDA should work to modify its reputation from that of an organization that merely approves drugs or inspects production facilities to a public-health agency focused on preventing illness, FDA Commissioner Dr. Margaret Hamburg wrote in an editorial in the New England Journal of Medicine. The article, co-authored by FDA Deputy Commissioner Dr. Joshua Sharfstein, also emphasized the need for policies to ensure safety in product approval, including conducting post-market studies of drugs and devices.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA